Project leads
Collaborators

HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium

Kathryn Anastos

12 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Follow

Kathryn Anastos

Yeshiva University

New York, United States

WE-ACTX

Kigali, Rwanda

Philip E Castle

Yeshiva University

New York, United States

Jean D Sinayobye

Yeshiva University

New York, United States

Jean Claude Dusingize

Yeshiva University

New York, United States

Howard Strickler

Yeshiva University

New York, United States

Leon Mutesa

University of Rwanda

Butare, Rwanda

Brenda Kateera

University of Rwanda

Butare, Rwanda

Joel Palefsky

University of California, San Francisco

San Francisco, United States

Qiuhu Shi

New York Medical College

Valhalla, United States

Adebola Adedimeji

Yeshiva University

New York, United States

Kathryn M Anastos

Yeshiva University

New York, United States

Xiaotao Cai

Data Solutions, LLC

Bronx, United States

Eugene Mutimura

WE-ACTX

Kigali, Rwanda

Regional Alliance For Sustainable Developement (Rasd)

Kigali, Rwanda

Women's Equity in Access to Care and Treatment for HIV

Kigali, Rwanda

Related projects

Robert L Murphy

Northwestern and Jos University Research Training Program in HIV and Malignancies

Melissa S. Lopez

Increasing clinical and research capacity for cancer in Mozambique. A multi-center collaboration between the U.S, Brazil and Mozambique

Cervix uteri Lip, oral cavity Larynx

Nicolas Wentzensen

Evaluation of the New IFCPC Colposcopy Nomenclature

E. Blair Holladay

Partners for Cancer Diagnostic and Treatment in Africa

Megan Fitzpatrick

HR-HPV in rural Zimbabwe

Surbhi Grover

A Study of Prevalence of HPV and Determinants of Poor Outcomes of HIV Positive and Negative Patients with Oropharyngeal Cancers in Botswana

Lip, oral cavity Other pharynx

Nathaniel Rothman

Studies in the Janus Cohort

Lip, oral cavity

Demetrius Albanes

Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study

Nicolas Wentzensen

Improving Cervical Cancer Prevention among HIV-Infected Women Using Novel HPV Based Biomarker Assays